NEW YORK, June 19, 2015 /PRNewswire/ --
3D Systems Corporation
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of 3D Systems
Corporation (DDD). Specifically, we are investigating DDD's
representations in connection with DDD's (i) ability to increase
the capacity of its metal printing business; (ii) demand for its
consumer products; (iii) the value of multiple companies it was
acquiring; and (iv) expected earnings.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Avalanche Biotechnologies, Inc.
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of Avalanche
Biotechnologies, Inc. (AAVL). Specifically, on June 15, 2015, AAVL announced that AAVL's
treatment for wet age-related macular degeneration met its primary
endpoint, but raised concerns by saying the study wasn't designed
to show statistically significant differences between the active
and control subjects in the secondary endpoints.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
FXCM Inc.
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of FXCM Inc.
(FXCM). Specifically, we are investigating FXCM's
representations in connection with FXCM's agency model of FX
trading insulating it from financial risk from its heavily
leveraged clients, whether FXCM adequately disclosed the true
potential risk posed by market volatility, and whether FXCM
maintained sufficient regulatory capital reserves for unforeseen
scenarios.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
KYTHERA Biopharmaceuticals, Inc.
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board in connection
with the proposed sale of KYTHERA Biopharmaceuticals, Inc.
(KYTH) to Allergan plc for $75 per
share, or approximately $2.1
billion.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
root9B Technologies Inc.
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of root9B
Technologies Inc. (RTNB). Specifically, on June 15, 2015, an author on
SeekingAlpha.com reported that it believes RTNB is a
worthless reverse merger shell led by the "The A-Team" of penny
stock wipeouts, questionable board members who have presided over
untold shareholder wealth destruction, and a management team with
ties to numerous fraud allegations.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Ryland Group Inc.
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Ryland Group Inc. ("RYL") to Standard Pacific Corp. Ryland
shareholders will own approximately 41% of the combined company.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2015 Lifshitz &
Miller. The law firm responsible for this advertisement is
Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)
493-9780. Prior results do not guarantee or predict a similar
outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-3d-systems-corporation-avalanche-biotechnologies-inc-fxcm-inc-kythera-biopharmaceuticals-inc-root9b-technologies-inc-and-ryland-group-inc-300102080.html
SOURCE Lifshitz & Miller Law Firm